Explore more uses of cas: 100-54-9 | Industrial & Engineering Chemistry Research

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Recommanded Product: 3-Cyanopyridine It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Recommanded Product: 3-CyanopyridineIn 2022, Zhu, Daoyun;Liu, Haiou;Huang, Yangqiang;Luo, Xiao;Mao, Yu;Liang, Zhiwu published 《Study of Direct Synthesis of DMC from CO2 and Methanol on CeO2: Theoretical Calculation and Experiment》. 《Industrial & Engineering Chemistry Research》published the findings. The article contains the following contents:

Rare earth metal oxides are known to have good catalytic effectiveness in the direct synthesis of di-Me carbonate (DMC) from CO2 and methanol. In this work, we screened ceria (CeO2) catalysts by analyzing their capacity for CO2 adsorption. The effects of the crystal surface morphol. and oxygen vacancy on the catalytic performance of the ceria catalyst were studied by using d. functional theory (DFT). The results show that the (110) surface and higher oxygen vacancy content can better promote the synthesis of DMC and that the rod-shaped CeO2 catalyst has a better catalytic effect. The oxygen vacancy content on the catalyst was improved by freeze-drying and confirmed by thermogravimetric anal., Raman spectroscopy, and ESR. The freeze-dried CeO2 (CeO2-FD) then showed a higher catalytic performance. The conversion rate of methanol and the yield of DMC were 33.95% and 584 mmol g-1cat, resp., under mild conditions (140°C and 1 MPa). The experimental procedure involved many compounds, such as 3-Cyanopyridine (cas: 100-54-9) .

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Recommanded Product: 3-Cyanopyridine It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Cas: 100-54-9 | Garcia-Garfido, Juan M.published an article in 2021

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Category: pyridine-derivatives It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Category: pyridine-derivatives《Millimeter-Scale Zn(3-ptz)2 Metal-Organic Framework Single Crystals: Self-Assembly Mechanism and Growth Kinetics》 was published in 2021. The authors were Garcia-Garfido, Juan M.;Enriquez, Javier;Chi-Duran, Ignacio;Jara, Ivan;Vivas, Leonardo;Hernandez, Federico J.;Herrera, Felipe;Singh, Dinesh P., and the article was included in《ACS Omega》. The author mentioned the following in the article:

The solvothermal synthesis of metal-organic frameworks (MOFs) often proceeds through competing crystallization pathways, and only partial control over the crystal nucleation and growth rates is possible. It challenges the use of MOFs as functional devices in free-space optics, where bulk single crystals of millimeter dimensions and high optical quality are needed. We develop a synthetic protocol to control the solvothermal growth of the MOF [Zn(3-ptz)2]n (MIRO-101), to obtain large single crystals with projected surface areas of up to 25 mm2 in 24 h, in a single reaction with in situ ligand formation. No addnl. cooling and growth steps are necessary. We propose a viable reaction mechanism for the formation of MIRO-101 crystals under acidic conditions, by isolating intermediate crystal structures that directly connect with the target MOF and reversibly interconverting between them. We also study the nucleation and growth kinetics of MIRO-101 using ex situ crystal image anal. The synthesis parameters that control the size and morphol. of our target MOF crystal are discussed. Our work deepens our understanding of MOF growth processes in solution and demonstrates the possibility of building MOF-based devices for future applications in optics. To complete the study, the researchers used 3-Cyanopyridine (cas: 100-54-9) .

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Category: pyridine-derivatives It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Learn more about cas: 100-54-9 | Synlett 2021

3-Cyanopyridine(cas: 100-54-9) also shows biological activity against autoimmune diseases, such as murine hepatitis, by inhibiting the proliferation of B cells and T cells.Name: 3-Cyanopyridine This drug is not effective against cancer cells because it does not inhibit DNA synthesis or protein synthesis.

Name: 3-Cyanopyridine《Decarbonylative Synthesis of Aryl Nitriles from Aromatic Esters and Organocyanides by a Nickel Catalyst》 was published in 2021. The authors were Iizumi, Keiichiro;Kurosawa, Miki B.;Isshiki, Ryota;Muto, Kei;Yamaguchi, Junichiro, and the article was included in《Synlett》. The author mentioned the following in the article:

A decarbonylative cyanation of aromatic esters with aminoacetonitriles in the presence of a nickel catalyst were developed. The key to this reaction were the use of a thiophene-based diphosphine ligand, dcypt, permitting the synthesis of aryl nitrile without the generation of stoichiometric metal- or halogen-containing chem. wastes. A wide range of aromatic esters, including hetarenes and pharmaceutical mols., were converted into aryl nitriles. To complete the study, the researchers used 3-Cyanopyridine (cas: 100-54-9) .

3-Cyanopyridine(cas: 100-54-9) also shows biological activity against autoimmune diseases, such as murine hepatitis, by inhibiting the proliferation of B cells and T cells.Name: 3-Cyanopyridine This drug is not effective against cancer cells because it does not inhibit DNA synthesis or protein synthesis.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

New progress of cas: 100-54-9 | Advanced Synthesis & Catalysis 2022

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Safety of 3-Cyanopyridine It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Safety of 3-Cyanopyridine《Site-Selective 1,4-Difunctionalization of Nitrogen Heteroaromatics for Constructing Vinylidene Heterocycles》 was published in 2022. The authors were He, Qianlin;Zhong, Mingli;Chen, Zhichao;Liao, Chuyi;Xie, Feng;Zhu, Zhongzhi;Chen, Xiuwen, and the article was included in《Advanced Synthesis & Catalysis》. The author mentioned the following in the article:

A one-pot protocol for constructing 1,4-difunctionalized quinoline/pyridine derivatives via the reaction of N-heteroaromatics, alkyl halides, and active methylene/methyl compounds was developed. The transformation involves dearomative functionalization of an in situ-activated N-heteroaromatic to construct new C-N and C=C bonds. This reaction has a broad substrate scope and functional group tolerance. And 3-Cyanopyridine (cas: 100-54-9) was used in the research process.

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Safety of 3-Cyanopyridine It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Cas: 100-54-9 | Song, Hao et al. made new progress in 2022

3-Cyanopyridine(cas: 100-54-9) also shows biological activity against autoimmune diseases, such as murine hepatitis, by inhibiting the proliferation of B cells and T cells.Electric Literature of C6H4N2 This drug is not effective against cancer cells because it does not inhibit DNA synthesis or protein synthesis.

Electric Literature of C6H4N2《Switching Selectivity in Copper-Catalyzed Transfer Hydrogenation of Nitriles to Primary Amine-Boranes and Secondary Amines under Mild Conditions》 was published in 2022. The authors were Song, Hao;Xiao, Yao;Zhang, Zhuohua;Xiong, Wanjin;Wang, Ren;Guo, Liangcheng;Zhou, Taigang, and the article was included in《Journal of Organic Chemistry》. The author mentioned the following in the article:

A simple and efficient copper-catalyzed selective transfer hydrogenation of nitriles to primary amine-boranes I [R = n-Bu, Ph, cyclohexyl, etc.] and secondary amines R1CH(R2)NHCH2R3 [R1 = Ph, 2-furyl, 1-naphthyl, etc.; R2 = H, Me; R3 = Ph, 4-MeC6H4, 3-thienyl, etc.] with an oxazaborolidine-BH3 complex was reported. The selectivity control was achieved under mild conditions by switching the solvent and the copper catalysts. More than 30 primary amine-boranes and 40 secondary amines were synthesized via this strategy in high selectivity and yields of up to 95%. The strategy was applied to the synthesis of 15N labeled in 89% yield.3-Cyanopyridine (cas: 100-54-9) were involved in the experimental procedure.

3-Cyanopyridine(cas: 100-54-9) also shows biological activity against autoimmune diseases, such as murine hepatitis, by inhibiting the proliferation of B cells and T cells.Electric Literature of C6H4N2 This drug is not effective against cancer cells because it does not inhibit DNA synthesis or protein synthesis.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Li, Fei-ze et al. published new experimental results with the assistance of cas: 100-54-9

3-Cyanopyridine(cas: 100-54-9) also shows biological activity against autoimmune diseases, such as murine hepatitis, by inhibiting the proliferation of B cells and T cells.Product Details of 100-54-9 This drug is not effective against cancer cells because it does not inhibit DNA synthesis or protein synthesis.

Product Details of 100-54-9《Proximity Effect in Uranyl Coordination of the Cucurbit[6]uril-Bipyridinium Pseudorotaxane Ligand for Promoting Host-Guest Synergistic Chelating》 was published in 2021. The authors were Li, Fei-ze;Geng, Jun-shan;Hu, Kong-qiu;Yu, Ji-pan;Liu, Ning;Chai, Zhi-fang;Mei, Lei;Shi, Wei-qun, and the article was included in《Inorganic Chemistry》. The author mentioned the following in the article:

The authors proposed regulating uranyl coordination behavior of cucurbituril-bipyridinium pseudorotaxane ligand by using meta-functionalized bipyridinium dicarboxylate guest. A tailored pseudorotaxane precursor involving 1,1′-(hexane-1,6-diyl)bis(3-cyanopyridin-1-ium) bromide (C6BPCN3) and cucurbit[6]uril (CB[6]) has been designed and synthesized. Through in situ hydrolysis of the pseudorotaxane ligands and their coordination assembly with uranyl cations, seven new uranyl-rotaxane coordination polymers URCP1-URCP7 were obtained under hydrothermal conditions in the presence of different anions. The variation of carboxylate groups from para- to meta-position affected the coordination of the meta-functionalized pseudorotaxane linkers, which are enriched from simple guest-only binding to host-guest simultaneous coordination and synergistic chelating. This effective regulation on uranyl coordination of supramol. pseudorotaxane can be attributed to the proximity effect, which refers to the meta-position carboxyl group being spatially closer to the portal carbonyl group of CB[6]. Also, by combining other regulation methods such as introducing competing counterions and modulating solution acidity, the nuclearity of the uranyl center and the coordination patterns of the pseudorotaxane ligand can be diversely tuned, which subsequently exert great influence on the final dimensionality of resultant uranyl compounds This work presents a large diversity of uranyl-based coordination polyrotaxane compounds with fascinating mech. interlocked components and, most importantly, provides a feasible approach to adjust and control the metal coordination behavior of the pseudorotaxane ligand that might expand the scope of application of such supramol. ligands.3-Cyanopyridine (cas: 100-54-9) were involved in the experimental procedure.

3-Cyanopyridine(cas: 100-54-9) also shows biological activity against autoimmune diseases, such as murine hepatitis, by inhibiting the proliferation of B cells and T cells.Product Details of 100-54-9 This drug is not effective against cancer cells because it does not inhibit DNA synthesis or protein synthesis.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Guo, Leilei et al. published new experimental results with the assistance of cas: 100-54-9

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Quality Control of 3-Cyanopyridine It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Guo, Leilei;Yang, Wenlong;Cheng, Xi;Fan, Zhixia;Chen, Ximeng;Ge, Feng;Dai, Yijun published 《Degradation of neonicotinoid insecticide acetamiprid by two different nitrile hydratases of Pseudaminobacter salicylatoxidans CGMCC 1.17248》. The research results were published in《International Biodeterioration & Biodegradation》 in 2021.Quality Control of 3-Cyanopyridine The article conveys some information:

Acetamiprid is a neonicotinoid insecticide used worldwide that has caused environmental pollution and adverse effects on ecosystems. Here, a novel bacterium, Pseudaminobacter salicylatoxidans CGMCC 1.17248, was isolated to rapidly degrade acetamiprid to IM-1-2 via hydration. Gene cloning and overexpression demonstrated that two nitrile hydratases, AnhA and AnhB, converted acetamiprid to IM-1-2. Escherichia coli overexpressing AnhA and AnhB degraded 98.1% and 94.0% of acetamiprid (1.0 mmol L-1) in 5 min and 8 h, resp. The pure AnhA and AnhB had a Vmax value of 14.12 and 1.20 μmol mg-1 min-1, resp., and a Km value of 1.02 mmol L-1 and 2.95 mmol L-1, resp. Compared with AnhA, AnhB had broad pH stability, as well as metal ions and organic solvents tolerance. Expression of AnhA and AnhB was induced by decreasing the nutrient concentration of culture broth and addition of urea and therefore significantly enhanced acetamiprid degradation of CGMCC 1.17248. qPCR indicated that the expression of AnhA and AnhB under the cultured conditions of 1/15 lysogeny broth or 0.5% urea addition was improved by from 2.2 to 5.3 times. The results presented herein will facilitate development of bioremediation agents for acetamiprid pollution and understanding of the functional role of bacterial nitrile hydratase.3-Cyanopyridine (cas: 100-54-9) were involved in the experimental procedure.

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Quality Control of 3-Cyanopyridine It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Cas: 100-54-9 | Rao, P. Purnachandrapublished an article in 2021

3-Cyanopyridine(cas: 100-54-9) also shows biological activity against autoimmune diseases, such as murine hepatitis, by inhibiting the proliferation of B cells and T cells.COA of Formula: C6H4N2 This drug is not effective against cancer cells because it does not inhibit DNA synthesis or protein synthesis.

Rao, P. Purnachandra;Nowshuddin, Shaik;Jha, Anjali;Rao, B. Leela Maheswara;Divi, Murali K.;Rao, M. N. A. published 《Bis-morpholinophosphorylchloride, a novel reagent for the conversion of primary amides into nitriles》. The research results were published in《Tetrahedron Letters》 in 2021.COA of Formula: C6H4N2 The article conveys some information:

Bis-morpholinophosphorylchloride(Bmpc),in the presence of a base,was an efficient dehydrating agent for both aromaticand aliphatic primary amides, and gives corresponding nitriles under mild conditions in good yields and purity. During the reaction the enantiomeric integrity remains intact. And 3-Cyanopyridine (cas: 100-54-9) was used in the research process.

3-Cyanopyridine(cas: 100-54-9) also shows biological activity against autoimmune diseases, such as murine hepatitis, by inhibiting the proliferation of B cells and T cells.COA of Formula: C6H4N2 This drug is not effective against cancer cells because it does not inhibit DNA synthesis or protein synthesis.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Learn more about cas: 100-54-9 | European Journal of Organic Chemistry 2021

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Application of 100-54-9 It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Application of 100-54-9In 2021, Zhuo, Liang;Xie, Shihua;Wang, Hui;Zhu, Hongjun published 《Aerobic Visible-Light Induced Intermolecular S-N Bond Construction: Synthesis of 1,2,4-Thiadiazoles from Thioamides under Photosensitizer-Free Conditions》. 《European Journal of Organic Chemistry》published the findings. The article contains the following contents:

Aerobic visible-light induced intermol. S-N bond construction has been achieved without the addition of photosensitizer, metal, or base. With this strategy, 1,2,4-thiadiazoles I (R = Ph, 4-methoxyphenyl, thiophen-3-yl, etc.; R1 = 4-methoxyphenyl, 2,6-dimethylphenyl, thiophen-2-yl, etc.) can be obtained from thioamides R/R1C(S)NH2. Preliminary mechanistic investigation suggested that the excited state of thioamides undergoes a single-electron-transfer (SET) process to afford thioamidyl radicals, which can be further transformed into a 1,2,4-thiadiazole through desulfurization and oxidative cyclization. The reaction has good functional group tolerance and represents a green method for the construction of S-N bonds.3-Cyanopyridine (cas: 100-54-9) were involved in the experimental procedure.

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Application of 100-54-9 It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Qiu, Shanguang et al. published new experimental results with the assistance of cas: 100-54-9

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Electric Literature of C6H4N2 It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Qiu, Shanguang;Chen, Yuxue;Song, Xinming;Liu, Li;Liu, Xi;Wu, Luyong published 《Potassium tert -Butoxide Promoted Synthesis of 4,5-Diaryl-2 H -1,2,3-triazoles from Tosylhydrazones and Nitriles》. The research results were published in《Synlett》 in 2021.Electric Literature of C6H4N2 The article conveys some information:

Intermol. cycloaddition of tosylhydrazones with nitriles was investigated. T-BuOK was shown to be an excellent base for increasing the effectiveness of the reaction in this protocol and homocoupling of the tosylhydrazones was significantly inhibited by using xylene as a solvent. Through this transformation, a variety of 4,5-diaryl-2 H-1,2,3-triazoles I [R1 = Ph, 4-MeC6H4, 4-ClC6H4, etc.; R2 = Ph, 3-BrC6H4, 2-thienyl, etc.] were prepared in good to excellent yields and with high purities. The process was azide-free and transition-metal-free.3-Cyanopyridine (cas: 100-54-9) were involved in the experimental procedure.

3-Cyanopyridine(cas: 100-54-9) is an antimicrobial agent that can be used in the treatment of infectious diseases.Electric Literature of C6H4N2 It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus pneumoniae.

Reference:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem